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*Pseudomonas aeruginosa* is the most pervasive of all recognized pathogens in the nosocomial environment, causing pulmonary and bloodstream infection with mortality rates of up to 50% ([@B1]). Multi-drug-resistant (MDR) *P. aeruginosa* strains are emerging with increasing frequency and infection rates have tripled over the past two decades ([@B2], [@B3]). Some *P. aeruginosa* strains have been found to be resistant to nearly all or all antibiotics in clinical use ([@B4]).

Cystic fibrosis (CF) patients infected with resistant *P. aeruginosa* are exposed to increased mortality and morbidity ([@B5], [@B6]) and estimates indicate that 25 to 45% of adult CF patients are chronically infected with MDR *P. aeruginosa* within their airway ([@B7]). The bacterium develops MDR phenotypes during its persistence in a CF patient's airway by accumulating pathoadaptive mutations ([@B8]). Whole-genome sequencing (WGS) can help to point out potential molecular mechanisms of resistance and has already proved to be able to predict antimicrobial susceptibility in several pathogens ([@B9], [@B10]). However, despite the fact that several WGS studies on *P. aeruginosa* CF lineages have been published ([@B11][@B12][@B14]), their evolutionary trajectories in relation to the development of antimicrobial resistance remain mostly unexplored to date.

To track the pathoadaptive changes leading to the development of MDR in *P. aeruginosa* during its microevolution in a CF patient's airway, we obtained whole-genome sequences of 40 *P. aeruginosa* clinical CF strains isolated at Trentino Regional Support CF Centre (Rovereto, Italy) from the sputum of a single CF patient over an eight-year period (2007 to 2014). Interestingly, despite a high degree of genome sequence conservation, isolates evolved toward the acquisition of an MDR phenotype over time.

Bacteria were grown in Luria-Bertani broth overnight at 37°C in a shaking incubator. Cells were harvested and genomic DNA was extracted using the DNeasy blood and tissue kit (Qiagen, Germany) following the manufacturer's instructions for Gram-negative bacteria. Genomic DNA libraries were prepared using the Nextera XT DNA library preparation kit and protocols (Illumina, USA) and sequenced on the Illumina MiSeq platform at the Next Generation Sequencing (NGS) Core Facility of the Centre for Integrative Biology, University of Trento. Assembly of draft genomes was carried out using SPAdes version 3.1.0 ([@B15]). To improve the assemblies' qualities, raw reads were mapped on the contigs using Bowtie2 v2.2.6 ([@B16]) and contigs with less than three reads mapping and/or with coverage below 1 were removed.

Identification of MLST profiles (sequence types) was performed *in silico* from *de novo* assembled genomes using MLST 1.8 ([Table 1](#tab1){ref-type="table"}) ([@B17]).

###### 

Draft genome sequences and global statistics of the 40 *P. aeruginosa* CF isolates

  Accession no.                                                       Isolate name   Yr of isolation   Sequence type   No. of contigs   Genome size (kb)   *N*~50~ (kb)   G+C content (%)
  ------------------------------------------------------------------- -------------- ----------------- --------------- ---------------- ------------------ -------------- -----------------
  [MAUO00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAUO00000000)   TNCF_3         2007              390             139              6,636              92             66.28
  [MAUP00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAUP00000000)   TNCF_4M        2007              390             161              6,630              78             66.29
  [MAUQ00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAUQ00000000)   TNCF_6         2007              390             356              6,618              31             66.28
  [MAUR00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAUR00000000)   TNCF_7M        2007              390             259              6,623              47             66.28
  [MAUS00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAUS00000000)   TNCF_10        2007              390             101              6,643              143            66.28
  [MAUT00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAUT00000000)   TNCF_10M       2007              390             107              6,633              111            66.29
  [MAZG00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZG00000000)   TNCF_12        2007              390             102              6,545              177            66.36
  [MAZI00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZI00000000)   TNCF_13        2007              390             75               6,637              195            66.27
  [MAZH00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZH00000000)   TNCF_14        2007              390             89               6,633              158            66.28
  [MAKL00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAKL00000000)   TNCF_16        2007              1864            59               6,638              269            66.28
  [MAZJ00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZJ00000000)   TNCF_23        2007              390             71               6,635              228            66.28
  [MAZK00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZK00000000)   TNCF_23M       2007              390             64               6,636              228            66.28
  [MAKM00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAKM00000000)   TNCF_32        2007              390             67               6,639              229            66.28
  [MAZL00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZL00000000)   TNCF_32M       2007              390             138              6,627              93             66.28
  [MAZM00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZM00000000)   TNCF_42        2008              390             70               6,639              228            66.28
  [MAZN00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZN00000000)   TNCF_42M       2008              390             71               6,640              228            66.28
  [MAZO00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZO00000000)   TNCF_49M       2008              390             76               6,635              177            66.29
  [MAZP00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZP00000000)   TNCF_68        2010              390             82               6,633              162            66.28
  [MAZQ00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZQ00000000)   TNCF_69        2010              1863            88               6,639              150            66.28
  [MAZR00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZR00000000)   TNCF_76        2010              390             61               6,634              281            66.28
  [MAZS00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZS00000000)   TNCF_85        2010              1864            101              6,644              124            66.29
  [MAZT00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZT00000000)   TNCF_88M       2010              1864            65               6,636              229            66.28
  [MAZU00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZU00000000)   TNCF_101       2011              1864            142              6,653              92             66.28
  [MAZV00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZV00000000)   TNCF_105       2011              390             92               6,644              191            66.28
  [MAZW00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZW00000000)   TNCF_106       2011              390             77               6,634              205            66.28
  [MAZX00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZX00000000)   TNCF_109       2011              390             69               6,634              205            66.28
  [MAZD00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZD00000000)   TNCF_130       2012              390             157              6,625              76             66.28
  [MAZF00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZF00000000)   TNCF_133       2012              390             82               6,637              154            66.29
  [MAZE00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAZE00000000)   TNCF_133_1     2012              1864            87               6,641              269            66.28
  [MAKK00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAKK00000000)   TNCF_151       2013              390             53               6,629              378            66.28
  [MBMI00000000](https://www.ncbi.nlm.nih.gov/nuccore/MBMI00000000)   TNCF_151M      2013              1864            103              6,636              143            66.28
  [MBMJ00000000](https://www.ncbi.nlm.nih.gov/nuccore/MBMJ00000000)   TNCF_154       2013              390             86               6,635              177            66.28
  [MBMK00000000](https://www.ncbi.nlm.nih.gov/nuccore/MBMK00000000)   TNCF_155       2013              390             62               6,634              339            66.28
  [MBML00000000](https://www.ncbi.nlm.nih.gov/nuccore/MBML00000000)   TNCF_155_1     2013              1923            71               6,635              221            66.28
  [MBMM00000000](https://www.ncbi.nlm.nih.gov/nuccore/MBMM00000000)   TNCF_165       2013              1923            119              6,634              135            66.28
  [MBMN00000000](https://www.ncbi.nlm.nih.gov/nuccore/MBMN00000000)   TNCF_167       2013              390             73               6,634              191            66.27
  [MBMO00000000](https://www.ncbi.nlm.nih.gov/nuccore/MBMO00000000)   TNCF_167_1     2013              390             91               6,628              143            66.28
  [MBMP00000000](https://www.ncbi.nlm.nih.gov/nuccore/MBMP00000000)   TNCF_174       2014              390             111              6,645              143            66.29
  [MBMQ00000000](https://www.ncbi.nlm.nih.gov/nuccore/MBMQ00000000)   TNCF_175       2014              390             118              6,642              124            66.28
  [MBMR00000000](https://www.ncbi.nlm.nih.gov/nuccore/MBMR00000000)   TNCF_176       2014              1923            61               6,637              354            66.28

The average number of contigs per genome was 101 with a standard deviation of 56. Draft genomes ranged in size from 6,545 kbp to 6,653 kb with a G+C content of 66.28% ([Table 1](#tab1){ref-type="table"}). The *N*~50~ of the draft genomes ranged from 30,645 to 378,317 bp with an average of 179.843 bp ([Table 1](#tab1){ref-type="table"}).

Accession number(s). {#s1}
--------------------

This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank. See [Table 1](#tab1){ref-type="table"} for accession numbers of the single genomes. The version described in this paper is the first one.

**Citation** Bianconi I, D'Arcangelo S, Benedet M, Bailey KE, Esposito A, Piffer E, Mariotto A, Baldo E, Dinnella G, Gualdi P, Schinella M, Donati C, Jousson O. 2016. Draft genome sequences of 40 *Pseudomonas aeruginosa* clinical strains isolated from the sputum of a single cystic fibrosis patient over an 8-year period. Genome Announc 4(6):e01205-16. doi:10.1128/genomeA.01205-16.

We thank Veronica De Sanctis and Roberto Bertorelli (NGS Facility at the Centre for Integrative Biology and LaBSSAH, University of Trento) for NGS sequencing and helpful discussions.

This work was supported by a donation from Associazione Trentina Fibrosi Cistica, Trento, Italy.
